BioSpace News Archive

Alira Health, a leading international healthcare and life sciences advisory firm, and Embleema, the innovative software provider for patient-driven healthcare data platforms, today announced a strategic partnership to develop next-generation real-world data solutions aimed at accelerating clinical innovation and improving patient outcomes.

Pieris Pharmaceuticals, Inc. today announced that it will host a third quarter 2020 investor call on Wednesday, November 4, 2020 at 8:00 AM EST to discuss financial results and provide a corporate update.

ENDRA Life Sciences Inc. announces it has been issued European Patent EP 3 294 142 B1 (the ‘142 patent) from the European Patent Office

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that it will report its third quarter 2020 financial and operating results on Wednesday, November 4, 2020, following the close of the U.S. financial markets. Lineage ma

Strive Health, a national innovator in value-based kidney care, announced that it has partnered with nearly 200 physicians and advanced practitioners from 20 nephrology groups across several states to participate in Medicare’s Comprehensive Kidney Care Contracting options of the Kidney Care Choices model.

Emerging Preclinical and Clinical Data Support Potential of Mesenchymal Stem Cells (MSCs) to be Useful in COVID-19 and Acute Respiratory Distress Syndrome (ARDS) from Other Causes ImStem’s MSC Product Candidate IMS001 is Derived from AgeX’s Stem Cell Line ESI-053 IMS001, which Recently Gained FDA IND Clearance to Begin Human Study in Multiple Sclerosis, to be Considered for Development in COVID-19 and ARDS More Generally

KYE Pharmaceuticals Inc. (“KYE”), a private company headquartered in Mississauga, Ontario focused on bringing medicines that fulfill clinically significant unmet needs to the Canadian market, today announced an important milestone, FIRDAPSE® (amifampridine phosphate), the first amifampridine product approved in Canada

Aphena Pharma Solutions Inc. announces the completion of its $7 million facility expansion and renovation in Easton, Marylan

Dental Professionals Providing Patients with Superior Aligners and Individualized Guidance at a Competitive Price Point

Targovax ASA, a clinical stage immuno-oncology company developing oncolytic viruses to target hard-to-treat solid tumors, announces the formation of a new Scientific Advisory Board.